Medicine Description cidophage-retard 850mg
Cidophage Retard is a medication that combines glibenclamide and metformin to manage blood glucose levels in individuals with type 2 diabetes. Glibenclamide functions as a sulfonylurea, promoting insulin secretion from the pancreas, thereby increasing insulin availability to lower blood sugar. Metformin, on the other hand, enhances insulin sensitivity in peripheral tissues, decreases hepatic glucose production, and slows intestinal glucose absorption. Together, these mechanisms work synergistically to improve glycemic control and mitigate the complications associated with diabetes.
Indications and Uses of Cidophage Retard
- Management of type 2 diabetes mellitus in adults
- Improvement of glycemic control in conjunction with dietary modifications and exercise
Side Effects of Cidophage Retard
- Nausea and vomiting
- Diarrhea
- Abdominal pain
- Hypoglycemia
- Lactic acidosis (rare but serious)
Storage and Handling
Store Cidophage Retard at room temperature, away from moisture and heat. Keep out of reach of children and do not use past the expiration date.
Patient Advice and Precautions
Patients should adhere to prescribed dietary and exercise regimens to optimize therapeutic outcomes. Regular monitoring of blood glucose levels is essential. Be cautious of potential hypoglycemic episodes and ensure to recognize the symptoms. Consult a healthcare provider before discontinuing or altering the medication regimen.